Neurotransmitters Involved in the Opioid Regulation of Prolactin Secretion at the End of Pregnancy in Rats
Authors:
- Marta SoajeMSMarta Soaje
- Claudia BregonzioCBClaudia Bregonzio
- Rubén W. CarónRCRubén W. Carón
- Ricardo P. DeisRDRicardo P. Deis
- 1 October 2004
- journal article
- Published by S. Karger AG in Neuroendocrinology
- Vol. 80 (1) , 11-20
Abstract
Using a pharmacological approach, we explored potential mechanisms for the regulation of prolactin secretion by opioid peptides at the end of pregnancy in rats. On day 19 of pregnancy, intracereboventricular administration of the µ-opioid receptor agonist (D-Ala2, NMe-Phe4, Gly-ol5)-enkephalin (DAMGO) or β-endorphin (β-END) induced a dose-related increase in serum prolactin levels 30 min later. Pretreatment with the opioid antagonist naloxone abolished the increase induced by DAMGO injection. At lower doses, DAMGO and β-END did not modify the 3,4-dihydroxyphenylacetic acid/dopamine ratio, but at higher doses, the µ-agonists evoked a significant increase of the dopaminergic activity as compared with saline control. The time course of the effects of β-END (2.5 µg/rat) showed a higher increase in serum prolactin levels at 15 min than at 30 min after treatment. The 3,4-dihydroxyphenylacetic acid/dopamine ratio increased 15 min after β-END administration and was even higher 30 min later. Neither the selective ĸ-agonist U50,488H nor the selective δ-agonist (D-Pen2, D-Pen5)- enkephalin were able to modify the serum prolactin levels at the doses studied.To evaluate potential neurotransmitters involved in the regulation of prolactin secretion at the end of pregnancy, we combined the administration of serotoninergic or GABAergic antagonists with the opioid agonist DAMGO. The serotonin 5-HT2 receptor antagonist ketanserin increased the serum prolactin levels and potentiated the effect of DAMGO. The intracerebroventricular administration of SR-95531 did not modify the serum prolactin concentration under basal conditions, but partially prevented the increase induced by DAMGO injection. The intracerebroventricular administration of the GABAB receptor antagonist phaclofen had no effect on the serum prolactin levels either in naive or DAMGO-treated rats. The present results support the proposal that activation of µ-opioid receptors stimulates prolactin secretion at the end of pregnancy. Although the exact mechanisms by which the opioid system modulates prolactin secretion at the end of pregnancy are unclear, these results suggest an interaction of the opioidergic system with serotoninergic and GABAergic systems, without ruling out a direct or indirect action on dopaminergic neurons. In conclusion, the opioid system may regulate prolactin secretion at the end of pregnancy through either stimulatory (present results) or inhibitory actions previously described.Keywords
This publication has 76 references indexed in Scilit:
- Dopamine as a Prolactin (PRL) InhibitorEndocrine Reviews, 2001
- Effect of Serotonin Depletion by p-Chlorophenylalanine on Serum Prolactin Levels in Estrogen-Treated Ovariectomized Rats: Insights Concerning the Serotoninergic, Dopaminergic and Opioid SystemsHormone and Metabolic Research, 2001
- Serotonergic regulation of renin and prolactin secretionBehavioural Brain Research, 1995
- Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implicationsTrends in Neurosciences, 1995
- Opioids act at μ-receptors to hyperpolarize arcuate neurons via an inwardly rectifying potassium conductanceBrain Research, 1990
- Biochemical and functional aspects on the control of prolactin release by the hypothalamo-pituitary GABAergic systemPsychoneuroendocrinology, 1989
- Preoptic area opioids and opiate receptors increase during pregnancy and decrease during lactationBrain Research, 1987
- Gonadal steroid modulation of brain opioid systemsJournal of Steroid Biochemistry, 1987
- Evidence for a role of endorphins in stress- and suckling-induced prolactin release in the ratMolecular and Cellular Endocrinology, 1978
- Radioimmunoassay for Rat ProlactinExperimental Biology and Medicine, 1969